Journal of Peking University(Health Sciences) ›› 2017, Vol. 49 ›› Issue (6): 974-978. doi: 10.3969/j.issn.1671-167X.2017.06.007

• Article • Previous Articles     Next Articles

Adipose tissue derived stem cells’ treatment effects in MRL/lpr mice and its effects on the imbalance of Th17/Treg cells

ZHANG Wei, PANG Chun-yan,WANG Yong-fu△   

  1. [Center Laboratory of First Hospital Affiliated of Baotou Medical College, Institute of Rheumatology and Immunology of Baotou Medical College (Inner Mongolia Key Laboratory of Autoimmunity), Baotou 014010, Inner Mongolia, China]
  • Online:2017-12-18 Published:2017-12-18
  • Contact: WANG Yong-fu E-mail: wyf5168@hotmail.com
  • Supported by:
    Supported by the Key Fundamental Research Project of Inner Mongolia, the College Scientific Research Project of Inner Mongolia (NJZC212) and the Medical and Health Research Project of Health and Family Planning Commission of Inner Mongolia (201301069)

Abstract: Objective: Preliminary study on therapeutic effects of adipose tissue derived stem cells (ADSCs) on MRL/lpr mice and the effect on imbalance of Th17/Treg. Methods: Fifteen 12-week-old MRL/lpr mice were randomly divided into 3 groups by using random number table, including ADSCs group, control group and cyclophosphamide (CTX) group, with 5 in each group. ADSCs group and control group were injected with 1×106 ADSCs or phosphate buffered solution (PBS) via tail vein respectively, once a week, a total of eight times. CTX group was injected CTX at a dose of 15 mg/kg body weight, once a week for 2 weeks, and then repeated after 2 weeks’ rest, a total of four times. The 24-hour proteinuria was measured before and after treatment. All the mice were sacrificed after treatment for 8 weeks. Th17 cells and Treg cells in splenic were examined by flow cytometry. Results: (1) The 24-hour proteinuria in the three groups had no significant difference before treatment (P>0.05). After therapy for 4 weeks, the 24-hour proteinuria in the ADSCs and CTX groups was much lower than those in control group, and the difference was significant [(5.02±1.61) g/L vs. (7.10±1.63) g/L, (4.90±0.71) g/L vs. (7.10±1.63) g/L, P<0.05], and the longer the duration of treatment (8 weeks), the more obvious effect [(2.24±0.73) g/L vs. (10.36±1.64) g/L, (3.80±1.45) g/L vs. (10.36±1.64) g/L, P<0.01]. There was no significant difference in 24-hour proteinuria between ADSCs group and CTX group (P>0.05). (2) Percentage of Treg cells /CD4+T cells in the spleen lymphocytes: The percentages in ADSCs and CTX groups were higher than that in control group. The levels were 13.62%±187%, 14.14%±1.29%, 10.71%±1.23%, respectively, but there was no significant difference (P>0.05). (3) Percentage of Th17 cells /CD4+T cells in the spleen lymphocytes: The percentages in ADSCs and CTX groups were significantly lower than that in control group. The levels were 1.43%±020%, 1.63%±0.65%, 6.37%±1.64%, respectively, with statistical significance (P<0.01). Conclusion: Transplantation of ADSCs can reduce the 24-hour proteinuria in MRL/lpr mice. To prolong the time of treatment, the effect is more significant. Transplantation of ADSCs can up-regulate Treg cells and down-regulate Th17 cells. ADSCs have the ability to regulate the immune balance of Th17/Treg in MRL/lpr mice, suggesting that ADSCs play the role of antiinflammatory and immune regulation by regulating the Treg and Th17 cells.

Key words: Adipose tissue, Mesenchymal stem cell transplantation, Lupus erythematosus, systemic, Disease models, animal, Mice, inbred MRL lpr

CLC Number: 

  • R392.1
[1] ZHANG Su-jie, ZHAO Wei-hong, YU Lu-ping, YIN Hua-qi, ZHANG Xiao-wei, LI Qing, LIU Shi-jun, XU Tao. Minimal fat renalangiomyolipoma with multiple lymph nodes enlargement and postoperative refractory lymphatic fistula: a case report and literature review [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 717-721.
[2] WANG Zi-cheng, CHENG Li, LV Tong-de, SU Li, LIN Jian, ZHOU Li-qun. Inflammatory priming adipose derived stem cells significantly inhibit the proliferation of peripheral blood mononuclear cells [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 590-594.
[3] SUI Hua-xin, LV Pei-jun, WANG Yu-guang, WANG Yong, SUN Yu-chun. Effect of lowlevel laser irradiation on proliferation and osteogenic differentiation of human adipose-derived stromal cells [J]. Journal of Peking University(Health Sciences), 2017, 49(2): 337-343.
[4] SONG Yang, WANG Xiao-fei, WANG Yu-guang, DONG Fan, LU Pei-jun. A preliminary study for the effect of nano hydroxyapatite on human adipose-derived mesenchymal stem cells mixture 3D bio-printing [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 894-899.
[5] ZHENG Yi-ming, DU Jing, LI Wen-zhu, WANG Zhao-xia, ZHANG Wei, XIAO Jiang-xi, YUAN Yun. Clinical application of MRI histogram in evaluation of muscle fatty infiltration [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 830-834.
[6] GE Wen-shu, TANG Yi-man, ZHANG Xiao, LIU Yun-song, ZHOU Yong-sheng. Establishing a luciferase reporter system to evaluate osteogenic differentiation potential of human adipose-derived stem cells [J]. Journal of Peking University(Health Sciences), 2016, 48(1): 170-174.
[7] SONG Yang, WANG Xiao-fei, WANG Yu-guang, SUN Yu-chun, LV Pei-jun. Osteogenesis of human adipose-derived mesenchymal stem cells-biomaterial mixture in vivo after 3D bio-printing [J]. Journal of Peking University(Health Sciences), 2016, 48(1): 45-50.
[8] ZHANG Xiao, LIU Yun-song, LV Long-wei, CHEN Tong, WU Gang, ZHOU Yong-sheng. Promoted role of bone morphogenetic protein 2/7 heterodimer in the osteogenic differentiation of human adipose-derived stem cells [J]. Journal of Peking University(Health Sciences), 2016, 48(1): 37-44.
[9] WANG Xiao-fei, LV Pei-jun, SONG Yang, WANG Yong, SUN Yu-chun. Short-term effect of CaCl2 on human adipose-derived mesenchymal stem cells proliferation and osteogenic differentiation [J]. Journal of Peking University(Health Sciences), 2015, 47(6): 971-976.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 456 -458 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 125 -128 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 135 -140 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 158 -161 .
[5] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 217 -220 .
[6] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 52 -55 .
[7] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 297 -301 .
[8] . [J]. Journal of Peking University(Health Sciences), 2009, 41(5): 599 -601 .
[9] . [J]. Journal of Peking University(Health Sciences), 2009, 41(5): 516 -520 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 304 -309 .